Fibroids
Key Points
- Fibroids (leiomyomas) are benign solid tumors arising from uterine smooth muscle.
- About half of affected patients may be asymptomatic, while others have substantial quality-of-life burden.
- Common symptom clusters include heavy menstrual bleeding, pelvic pain/pressure, urinary and bowel symptoms, dyspareunia, and infertility.
- Fibroid growth is hormonally responsive (estrogen/progesterone) and often slows or regresses after menopause.
Pathophysiology
Fibroids are benign uterine smooth-muscle tumors. They are hormonally responsive and tend to enlarge under endogenous estrogen/progesterone stimulation.
Clinical burden is heterogeneous. Many patients have no symptoms, but symptomatic disease can produce bleeding, pain, mass-effect urinary/bowel complaints, and reproductive challenges.
Fibroids are usually slow growing and frequently regress with menopause as ovarian hormone levels decline.
Classification
- Asymptomatic fibroids: Incidentally identified, no current functional burden.
- Symptomatic fibroids: Bleeding, pain, pressure, urinary/bowel, sexual, or fertility-related impacts.
- Fertility-preserving pathway: Medical control plus myomectomy-focused planning.
- Definitive pathway: Hysterectomy-based management when fertility is not desired and symptoms persist.
Nursing Assessment
NCLEX Focus
Prioritize symptom burden and fertility goals to guide treatment-pathway counseling.
- Characterize bleeding burden, pelvic pain/pressure pattern, and cycle impact.
- Assess urinary and bowel compression symptoms (frequency/retention, constipation).
- Assess dyspareunia and psychosocial quality-of-life effects.
- Clarify fertility priorities before discussing procedural options.
- Note that exam palpation may be nondiagnostic; pelvic ultrasound is primary imaging confirmation.
- Trend anemia-risk labs in heavy bleeding contexts (hemoglobin, hematocrit, ferritin).
Nursing Interventions
- Provide education on benign nature, expected natural history, and symptom-monitoring plan.
- Reinforce adherence to follow-up and individualized treatment planning.
- Support shared decision-making by aligning options with bleeding severity and fertility goals.
- Reinforce tiered management: hormonal options or LNG-IUD, nonhormonal tranexamic-acid pathway when appropriate, GnRH analog escalation, and procedure selection by goals.
- Teach key safety limits for tranexamic acid (thromboembolic-risk contexts, including thrombosis/hypercoagulopathy history and selected combined-hormonal-use contexts).
- Explain surgical options clearly: myomectomy (uterus preserving), uterine-artery embolization, and hysterectomy as definitive treatment.
- Teach return precautions for escalating bleeding, severe pain, or new instability symptoms.
Fertility-Pathway Mismatch
Fibroid treatment decisions that do not account for reproductive goals can cause avoidable harm or unwanted loss of fertility options.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| hormonal-therapy | Estrogen-progestin and progestin-based pathways | Used in selected cases for bleeding-control support; hormonal contraceptives are used symptomatically and are not considered fibroid-growth stimulants in this source context. |
| levonorgestrel-intrauterine-system | Progestin-releasing intrauterine system | May reduce heavy bleeding in symptomatic fibroid care when fertility planning and anatomy are appropriate. |
| tranexamic-acid | Oral tranexamic acid | Nonhormonal bleeding-reduction option; avoid in elevated thromboembolic-risk settings. |
| gnrh-analogs | Leuprolide-class options | Can shrink fibroids and are often used before planned surgery. |
Clinical Judgment Application
Clinical Scenario
A patient reports progressively heavier periods, pelvic pressure, and urinary frequency that now interfere with work and sleep.
- Recognize Cues: Combined bleeding and mass-effect symptoms suggest symptomatic uterine fibroids.
- Analyze Cues: Quality-of-life burden is significant and requires structured treatment planning.
- Prioritize Hypotheses: Stabilize bleeding burden and identify best long-term option based on fertility goals.
- Generate Solutions: Coordinate diagnostic confirmation and discuss medical versus procedural pathways.
- Take Action: Implement symptom-control plan and expedited gynecologic follow-up.
- Evaluate Outcomes: Symptoms improve and treatment selection aligns with patient priorities.
Related Concepts
- benign-reproductive-growths - Fibroids are a core subtype of benign uterine growth disorders.
- abnormal-uterine-bleeding - Heavy bleeding from fibroids is a common AUB pathway.
- causes-of-infertility - Fibroids may impair fertility depending on location and burden.
- endometrial-polyps - Differential structural causes of abnormal uterine bleeding often overlap.
Self-Check
- Which symptom pattern best distinguishes asymptomatic from clinically significant fibroid disease?
- How do reproductive goals change fibroid treatment selection?
- Why can symptoms improve after menopause in many fibroid cases?